The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma

Conditions: Recurrent Glioblastoma Interventions: Drug: Sintilimab; Radiation: Low-dose Radiotherapy Sponsors: Fifth Affiliated Hospital, Sun Yat-Sen University Recruiting

Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials